The IPOX® Update 4/18/2026
U.S.
Cerebras Targets $35 Billion Valuation in Upcoming U.S. IPO
AI chipmaker Cerebras has filed for a $3 billion initial public offering in the second quarter of 2024, seeking a massive $35 billion valuation. The public offering strategy is heavily centered on a new partnership with OpenAI, which has committed over $20 billion to purchase chips and could acquire up to a 10% equity stake in the firm. This strategic alliance underscores the soaring global demand for advanced AI inference hardware as both companies continue to shape the computing landscape. (Source)
Madison Air Solutions Achieves $15.65 Billion Valuation in Blockbuster NYSE Debut
HVAC and data center cooling firm Madison Air Solutions completed a highly successful New York Stock Exchange debut, raising $2.23 billion in the largest industrials listing since 1999. Shares surged significantly to secure a $15.65 billion valuation, highlighting robust investor demand for AI-related infrastructure. Commenting on the offering, IPOX® Vice President Kat Liu noted that its heavy oversubscription and premium pricing signal a definitive return of investor appetite for proven cash generating businesses despite an uneven market. (Source)
Inspire Brands Selects Underwriters for Potential $2 Billion U.S. Listing
Roark Capital has selected leading investment banks to orchestrate a U.S. initial public offering for Inspire Brands, the parent company of popular fast-food chains like Dunkin', Arby's, and Jimmy John's. The highly anticipated listing could take place as soon as this year and is projected to raise approximately $2 billion. Underwriters for the offering include major financial institutions such as JPMorgan Chase & Co., Bank of America Corp., Barclays Plc, Goldman Sachs Group Inc., and Morgan Stanley. (Source)
EagleRock Explores Rare U.S. Oil and Gas IPO Targeting $2 Billion Valuation
Permian-focused land management firm EagleRock has filed for a New York Stock Exchange IPO under the ticker "EROK" following a massive revenue jump to $72.2 million in fiscal year 2025. Guided by underwriters including Goldman Sachs, J.P. Morgan, and Barclays, the company is targeting a valuation between $1 billion and $2 billion as investor interest shifts toward energy assets and AI-driven power demand. By holding surface rights across 236,000 acres, the firm collects lucrative royalties without producing, offering a rare and attractive oil and gas listing to the public market. (Source 1) (Source 2)
Kailera Therapeutics Surges 62.5% in $625 Million Nasdaq Debut
Kailera Therapeutics achieved a massive $625 million initial public offering on the Nasdaq, signaling a potential turnaround for the broader biotech listing market. Shares of the company surged an impressive 62.5% on their first day of trading, driven by the intense global demand for advanced GLP-1 weight-loss drugs. Highlighting this trend, IPOX® Research Associate Lukas Muehlbauer stated, "Obesity remains one of the few areas in biotech with clear investor appetite," noting that near-term trading relies heavily on broader obesity-drug space fundamentals. (Source)
Crypto Exchange Kraken Confidentially Files for U.S. IPO
U.S.-based cryptocurrency exchange Kraken has officially submitted a confidential IPO registration with the Securities and Exchange Commission. The move was publicly confirmed by the company's co-CEO, though specific details regarding the offering's size, valuation, or selected underwriters remain undisclosed. This strategic filing comes despite the exchange previously freezing its listing plans just last month amid a sudden plunge in broader cryptocurrency prices. (Source)
Blackstone-Backed Liftoff Files for Nasdaq Listing Amid Tech Rebound
Mobile app marketing firm Liftoff, backed by Blackstone, has officially filed for a U.S. IPO on the Nasdaq under the ticker symbol "LFTO" after previously pausing its plans. The company is actively capitalizing on easing geopolitical tensions and a broader rebound in technology stocks to successfully enter the public equity markets. IPOX® Research Associate Lukas Muehlbauer noted that Liftoff is strategically utilizing this reopening IPO window as investors view the recovering software space as increasingly attractive for new equity listings. (Source)
U.S. IPO Market Remains Resilient Despite Geopolitical Volatility
A diverse slew of companies across the biotech and real estate sectors launched their initial public offering roadshows recently, pushing forward with listing plans despite ongoing conflicts in the Middle East. While the market initially struggled for momentum in February and March due to sudden volatility, the current issuance window has shown remarkable durability and continued institutional support. Analyzing the trend, IPOX® Associate Lukas Muehlbauer stated that "2026 is still on track to be the best year for IPOs since the post-pandemic drought, and it may even get there without the mega listings." (Source)
Defense Tech IPOs Show Strength Amid Global Geopolitical Tensions
The number of defense-tech unicorns in North America has rapidly quadrupled since 2020, reaching 24 companies as geopolitical risks continue to fuel heavy investment into the sector. Military clashes involving the U.S., Israel, and Iran have driven both private capital and public market activity, making the defense space increasingly attractive for upcoming listings. Commenting on the environment, IPOX® CEO Josef Schuster said, "Because it is less directly affected by stock market volatility, the IPO market in the defense sector is quite robust." (Source)
Europe
Uzbekistan's National Investment Fund Secures BlackRock for Dual London IPO
Uzbekistan's National Investment Fund has successfully signed cornerstone agreements with major global entities including BlackRock, Franklin Resources, Redwheel, and Allan & Gill Gray ahead of its initial public offering. The agreements cover roughly $300 million of global depositary receipts for the dual listing on both the London Stock Exchange and the Tashkent exchange. This marks the first time an Uzbek state-backed entity will access global equity markets, offering investors stakes in 13 state-owned firms across multiple key sectors as part of broader economic reforms. (Source)
Asia-Pacific
Syngenta Group Targets $10 Billion in Confidential Hong Kong IPO
Agricultural giant Syngenta Group, a subsidiary of Sinochem Holdings, is planning a confidential Hong Kong initial public offering as early as June. The listing aims to raise between $5 billion and $10 billion, which would make it the largest equity offering in the city since 2019. Supported by heavy-hitting sponsors like CICC, UBS, Bank of America, Goldman Sachs, and Citic Securities, the firm is pivoting to Hong Kong after previously dropping its Shanghai IPO plans. (Source)
GIC-Backed Envision AESC Explores $2 Billion Hong Kong Listing
Lithium-ion battery manufacturer Envision AESC, backed by Singapore's GIC Pte and HSG, is exploring a potential Hong Kong initial public offering. The proposed share sale could raise up to $2 billion, though specific valuation ranges and exact timing remain officially undisclosed. The company is actively working with financial institutions including China Merchants Securities Co., Deutsche Bank AG, and Huatai Securities Co. to orchestrate the offering as global EV demand continues. (Source)
MENA
Banque du Caire Prepares for $1.5 Billion IPO to Lead MENA Market Revival
Egyptian state-owned lender Banque du Caire is readying an initial public offering that could launch as early as the second quarter of 2026. The government plans to sell up to a 40% stake in the bank, targeting an approximate valuation of $1.5 billion amid a broader national privatization wave. Underwritten by CI Capital and EFG Hermes, the IPO pricing will likely be based on a price-to-book discount to peer CIB, capitalizing on the bank's strong 2025 net profit of E£16.13 billion. (Source)
Disclaimer: News summaries may contain mistakes. The information does not constitute financial advice, endorsement or recommendation and should not be considered as such.
